UBS’s Calpine Corporation CPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.12M Buy
51,700
+49,100
+1,888% +$1.11M ﹤0.01% 3472
2014
Q2
$62K Sell
2,600
-7,600
-75% -$172K ﹤0.01% 6597
2014
Q1
$213K Sell
10,200
-45,200
-82% -$887K ﹤0.01% 5125
2013
Q4
$1.08M Buy
55,400
+38,900
+236% +$756K ﹤0.01% 3456
2013
Q3
$321K Buy
16,500
+5,500
+50% +$109K ﹤0.01% 4616
2013
Q2
$234K Buy
+11,000
New +$231K ﹤0.01% 4931

Other funds holding CPN

UBS's CPN Position: Q3 2014 in Review

UBS reduced its Calpine Corporation (CPN) stake by 3% in Q3 2014, selling an estimated $524K and leaving 742,991 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1095.

UBS first reported a position in CPN in Q2 2013 and has held it in 6 quarters since. The position peaked at $29.1M in Q2 2013. 315 funds tracked by Wall St. Rank hold CPN as of Q3 2014.

  • UBS held 742,991 shares of Calpine Corporation worth $16.1M as of Q3 2014.
  • UBS sold 23,163 Calpine Corporation shares in Q3 2014, an estimated $524K.
  • Calpine Corporation made up 0.01% of UBS's portfolio in Q3 2014, its #1095 holding.
  • UBS first reported a position in Calpine Corporation in Q2 2013 and has held it in 6 quarters since.
  • UBS's Calpine Corporation position peaked at $29.1M in Q2 2013.
  • 315 funds tracked by Wall St. Rank held Calpine Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.